Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kirkpatrick

Showing results (251-260 of 308) with videos related to

Pageof 31
Sort By:
Medical Mycology|March 17, 2007
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipientSteven D Westbrook, William R Kirkpatrick, Cesar O Freytes, et al.
Journal of Clinical Pathology|November 4, 2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosisElaine McCulloch, Gordon Ramage, Ranjith Rajendran, et al.
Infection and Immunity|January 23, 1999
Neisseria gonorrhoeae mutants altered in toxicity to human fallopian tubes and molecular characterization of the genetic locus involvedC G Arvidson, R Kirkpatrick, M T Witkamp, et al.
The Journal of Infectious Diseases|October 1, 1996
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patientsS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology|December 8, 2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patientsA K Burn, A W Fothergill, W R Kirkpatrick, et al.
Expert Review of Clinical Pharmacology|May 4, 2016
Pain transduction: a pharmacologic perspectiveDan M McEntire, Daniel R Kirkpatrick, Nicholas P Dueck, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancerSpencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Journal of Clinical Microbiology|December 23, 2011
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detectionMartina Lengerova, Iva Kocmanova, Zdenek Racil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 1998
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patientsS G Revankar, O P Dib, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsS Perea, J L López-Ribot, W R Kirkpatrick, et al.
Pageof 31

Showing results (251-260 of 308) with videos related to

Sort By:
Pageof 31
Medical Mycology|March 17, 2007
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipientSteven D Westbrook, William R Kirkpatrick, Cesar O Freytes, et al.
Journal of Clinical Pathology|November 4, 2011
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosisElaine McCulloch, Gordon Ramage, Ranjith Rajendran, et al.
Infection and Immunity|January 23, 1999
Neisseria gonorrhoeae mutants altered in toxicity to human fallopian tubes and molecular characterization of the genetic locus involvedC G Arvidson, R Kirkpatrick, M T Witkamp, et al.
The Journal of Infectious Diseases|October 1, 1996
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patientsS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Journal of Clinical Microbiology|December 8, 2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patientsA K Burn, A W Fothergill, W R Kirkpatrick, et al.
Expert Review of Clinical Pharmacology|May 4, 2016
Pain transduction: a pharmacologic perspectiveDan M McEntire, Daniel R Kirkpatrick, Nicholas P Dueck, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancerSpencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Journal of Clinical Microbiology|December 23, 2011
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detectionMartina Lengerova, Iva Kocmanova, Zdenek Racil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 1998
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patientsS G Revankar, O P Dib, W R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2001
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patientsS Perea, J L López-Ribot, W R Kirkpatrick, et al.
Pageof 31